Which antipsychotics are FDA-approved for ASD-related behavior
Therefore, Novo Nordisk does not conclude a causal relationship between GLP-1 RA use, semaglutide and age-related macular degeneration at this time. Dr Alison Cave, the chief safety officer of the Medicines & Healthcare products Regulatory Agency, a UK watchdog, said: Macular degeneration is not currently listed as a potential side-effect of these medicines
Just be sure you stick to quality supplement brands that dont contain weird fillers
Weight rebound typically occurs slower with tirzepatide cessation compared to stopping oral medications, giving you a window to transition to maintenance strategies or switch to alternative approaches
But the right medication depends on safety, side effects, coverage, dose tolerance, and the patients long-term plan